Brighthouse Financial, Inc. (BHF)
Official siteFINANCIAL SERVICES • INSURANCE - LIFE • NASDAQ
Market Cap: $2.52B
Last updated: Nov 17, 2026 at 11:04 AM ET
Brighthouse Financial, Inc. (BHF) Stock Forecast
Analysts expect Brighthouse Financial (BHF) to earn $19.63 per share in the fiscal year ending Dec 31, 2026, on revenue of $8.61B. Of 7 analysts, 0 rate the stock Buy or Strong Buy, 7 Hold and 0 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 1 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 7 ratings average 3.00, inside the Hold band from 2.5 up to 3.5. All 7 rate it Hold.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 0 | 0.0% |
| Hold | 7 | 100.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Hold
- Total analysts
- 7
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus falls 0.2% and revenue estimates rise 1.4%.
- Fiscal year ending Dec 31, 2026
- $19.63
- EPS consensus, revenue $8.61B
- Fiscal year ending Dec 31, 2027
- $19.60
- EPS consensus, revenue $8.73B
- Next report
- Feb 22, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $19.63 | $17.28 to $21.90 | 5 | $8.61B | $8.48B to $8.98B | 4 |
| Dec 31, 2027 | $19.60 | $16.25 to $23.45 | 4 | $8.73B | $8.36B to $9.43B | 4 |
Quarterly Estimates
The EPS consensus rises from $4.79 for the quarter ending Dec 31, 2026 to $5.22 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $4.79 | $4.11 to $5.50 | 7 | $2.21B | $2.14B to $2.30B | 3 |
| Mar 31, 2027 | $5.22 | $4.83 to $5.85 | 3 | $2.35B | $2.35B to $2.35B | 1 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 1 upward and 6 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 1 |
| Fiscal year ending Dec 31, 2027 | 0 | 2 |
| Quarter ending Mar 31, 2027 | 0 | 3 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 6.6% from $18.41.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $19.63 | $19.85 | $18.99 | $18.41 | $18.41 | +6.6% |
| Fiscal year ending Dec 31, 2027 | $19.60 | $20.08 | $20.09 | $20.14 | $20.14 | -2.7% |
| Quarter ending Mar 31, 2027 | $5.22 | $5.00 | $5.24 | $5.24 | $5.24 | -0.3% |
Frequently Asked Questions About BHF
What is the BHF stock forecast?
Consensus analyst estimates put Brighthouse Financial's EPS at $19.63 for the fiscal year ending Dec 31, 2026, on revenue of $8.61B. The consensus rating from 7 analysts is Hold.
How do analysts rate BHF stock?
Of 7 analysts covering Brighthouse Financial, 0 rate it Strong Buy, 0 Buy, 7 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from BHF next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $19.63, with estimates from $17.28 to $21.90 from 5 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $19.60, with estimates from $16.25 to $23.45 from 4 analysts.
What revenue do analysts expect from Brighthouse Financial next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $8.61B, with estimates from $8.48B to $8.98B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $8.73B, with estimates from $8.36B to $9.43B.
How many analysts cover BHF?
7 analysts rate Brighthouse Financial stock, and 5 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
BHF pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors